# Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

> **NCT04309994** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 307 (actual)

## Conditions studied

- Heart Attack
- Cardioplegia Solution Adverse Reaction
- Coronary Artery Bypass Grafting (CABG)

## Interventions

- **OTHER:** Myocardial protection system (MPS)
- **OTHER:** Cardioplexol

## Key facts

- **NCT ID:** NCT04309994
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309994, "Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04309994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*